BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30504807)

  • 1. Thrombin generation during a regular menstrual cycle in women with von Willebrand disease.
    Govorov I; Bremme K; Lindahl TL; Holmström M; Komlichenko E; Chaireti R; Mints M
    Sci Rep; 2018 Nov; 8(1):17467. PubMed ID: 30504807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood inflammatory and endothelial markers in women with von Willebrand disease.
    Govorov I; Bremme K; Larsson A; Holmström M; Komlichenko E; Chaireti R; Mints M
    PLoS One; 2019; 14(1):e0210544. PubMed ID: 30629692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle.
    Chaireti R; Gustafsson KM; Byström B; Bremme K; Lindahl TL
    Hum Reprod; 2013 Jul; 28(7):1846-52. PubMed ID: 23592222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.
    Kadir RA; Economides DL; Sabin CA; Pollard D; Lee CA
    Haemophilia; 1999 Jan; 5(1):40-8. PubMed ID: 10215946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey.
    Kouides PA; Phatak PD; Burkart P; Braggins C; Cox C; Bernstein Z; Belling L; Holmberg P; MacLaughlin W; Howard F
    Haemophilia; 2000 Nov; 6(6):643-8. PubMed ID: 11122390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor for menorrhagia: a survey and literature review.
    Ragni MV; Machin N; Malec LM; James AH; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brambilla DJ
    Haemophilia; 2016 May; 22(3):397-402. PubMed ID: 26843404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women and von Willebrand disease: controversies in diagnosis and management.
    Kadir RA; Chi C
    Semin Thromb Hemost; 2006 Sep; 32(6):605-15. PubMed ID: 16977570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menorrhagia and bleeding disorders in adolescent females.
    Halimeh S
    Hamostaseologie; 2012; 32(1):45-50. PubMed ID: 22127528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand disease and women's health.
    Lee CA; Abdul-Kadir R
    Semin Hematol; 2005 Jan; 42(1):42-8. PubMed ID: 15662615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand disease and bleeding in women.
    Ragni MV; Bontempo FA; Hassett AC
    Haemophilia; 1999 Sep; 5(5):313-7. PubMed ID: 10583512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease.
    Eising HP; Sanders YV; de Meris J; Leebeek FWG; Meijer K
    Haemophilia; 2018 Nov; 24(6):950-956. PubMed ID: 29989261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of the laboratory identification of von Willebrand disease in women.
    Kouides PA
    Semin Thromb Hemost; 2006 Jul; 32(5):480-4. PubMed ID: 16862520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic and therapeutic strategies for intraoperative bleeding in women with von Willebrand disease and heavy menstrual bleeding: A systematic review.
    Eising HP; Punt MC; Leemans JC; Bongers MY
    Blood Rev; 2023 Nov; 62():101131. PubMed ID: 37716881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of von Willebrand's disease in women - some answers, more questions.
    Kouides PA
    Haemophilia; 2006 Jul; 12 Suppl 3():143-51. PubMed ID: 16684010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-generating capacity in patients with von Willebrand's disease.
    Rugeri L; Beguin S; Hemker C; Bordet JC; Fleury R; Chatard B; Negrier C; Dargaud Y
    Haematologica; 2007 Dec; 92(12):1639-46. PubMed ID: 18055987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand disease and aging: an evolving phenotype.
    Sanders YV; Giezenaar MA; Laros-van Gorkom BA; Meijer K; van der Bom JG; Cnossen MH; Nijziel MR; Ypma PF; Fijnvandraat K; Eikenboom J; Mauser-Bunschoten EP; Leebeek FW;
    J Thromb Haemost; 2014 Jul; 12(7):1066-75. PubMed ID: 24750783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease.
    Brown MC; White MH; Friedberg R; Woods K; Childress K; Kulkarni M; Sidonio RF
    Res Pract Thromb Haemost; 2021 May; 5(4):e12513. PubMed ID: 33977212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Center Experience of von Willebrand Disease (vWD) Among Patients with Menorrhagia: A Diagnosis which could be Missed.
    Hassan R; Yusof WA; Hussain NH; Abdullah WZ
    Indian J Hematol Blood Transfus; 2012 Sep; 28(3):157-61. PubMed ID: 23997452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.
    Holm E; Carlsson KS; Lövdahl S; Lail AE; Abshire TC; Berntorp E
    Haemophilia; 2018 Jul; 24(4):628-633. PubMed ID: 29626372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.